Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

NIH seeks licensees for antigenic MMP peptides with potential as therapeutic and diagnostic agents

Oct. 25, 1996

MMP/TNF production inhibitors reported by Pfizer

Oct. 25, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Important milestone for Connective Therapeutics' ConXn

Oct. 11, 1996

Federal research grant for novel genetic approach to arthritis

Oct. 11, 1996

Celecoxib development status in Japan

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...